| Price | 1.01 |
| Price Change Today | -$0.03 (-2.88%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $1.06 |
| Previous Close | $1.04 |
| Daily Range | $0.95 - $1.07 |
| 52-Week Range | $0.70 - $9.82 |
| Volume | 685,137 |
| Stemcells, Inc. is engaged in research aimed at the development of therapies that would use stem and progenitor cells derived from fetal or adult sources to treat, and possibly cure, human diseases and injuries such as Parkinson's disease, hepatitis, diabetes, and spinal cord injuries. | |





END TARGET 1.68 and higher...
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment